It’s time for CARF to grow. Today, all the pieces have come together for CARF to expand its patient outreach, services and investment in research. The combination of hair loss discoveries and increased clinical interest, a fast-growing patient population, and strong organizational leadership has placed CARF in a unique position to be more valuable than ever before.
This next era in scarring alopecia research is about understanding more about known pathways, the triggers that cause this hair loss, and what role does genetics plays in some of these conditions. With the powerful techniques of genomics, proteomics, and lipidomics, there is massive amounts of information coming out now that will push this field forward in great leaps and bounds.
It’s really an exciting time and CARF wants you to be a part of it! CARF plays an integral part in the process of developing new and improved therapies and, potentially, a cure, because we are the only patient group in the world that is exclusively devoted to scarring alopecia, with over 5000 members.